Skip to content
Clinical Trials – home

Rare diseases

Investigational molecules

Locations

Our offerNewsroom

Fraunhofer Institute For Translational Medicine And Pharmacology ITMP
Sponsor

Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Germany Sandhoefer Allee 1, Niederrad, 60528 Frankfurt, Germany

About the sponsor

Research activity includes severe, treatment-refractory immune-mediated inflammatory diseases with a focus on rheumatoid arthritis, systemic sclerosis, primary Sjögren’s disease, and idiopathic inflammatory myopathy.

  • BCMAxCD3 bispecific T-cell engaging therapy
  • Severe refractory autoimmune inflammation
  • Connective tissue disease
  • Inflammatory myopathy

The therapeutic emphasis is on complex autoimmune conditions with persistent disease activity despite prior treatment.

About Specializations

Fraunhofer Institute For Translational Medicine And Pharmacology ITMP runs clinical trials in conditions such as Anti-neutrophil cytoplasmic antibody positive vasculitis, Attention deficit hyperactivity disorder, Major depression, Enterococcal infection, among others.

Recruiting now

Ongoing trials

Clinical trials run by this sponsor – those enrolling participants first.

Condition
Country
City
Type of trial
Recruitment status
Quick filters

5 clinical trials

Anti-neutrophil cytoplasmic antibody positive vasculitis

Recruiting

A Study of CND261 for Patients with Active ANCA-Positive Vasculitis That Has Not Responded to Previous Treatments

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Attention deficit hyperactivity disorder+1

Recruiting

Study on the Safety and Effectiveness of Dexamfetamine Sulfate for Adults with ADHD and Moderate to Severe Depression

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years
  • Substances:Dexamfetamine Sulfate
  • Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Enterococcal infection

Not yet recruiting

Effectiveness and Safety of INTESTIFIX in Removing Vancomycin‑Resistant Enterococci Colonization in Immunocompromised Patients – drug combination

Registered drug
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Ascorbic Acid
  • Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Systemic scleroderma+3

Not recruiting

A Study of Cizutamig for Patients with Severe Autoimmune Inflammatory Diseases That Did Not Respond to Previous Treatments

InvestigationalNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Chronic spontaneous urticaria

Not recruiting

Study on the Effectiveness and Safety of Danicopan for Adults with Chronic Spontaneous Urticaria Resistant to H1-Antihistamines

Registered drugNo placebo
Countries:GermanyGermany
  • Participants:18–64 years · 65+ years
  • Substances:Danicopan
  • Sponsor:Fraunhofer Institute For Translational Medicine And Pharmacology ITMP

Are you running a clinical trial?

Increase visibility for your trials and help patients find your site through our platform.

Join now →
Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.